The company said under a collaboration with the university it would invest £50m over three years to find out whether cancers could be prevented from developing with jabs.

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

We recently compiled a list of the Billionaire Larry Robbins’ Long-Term Stock Picks. In this article, we are going to take a ...

The Trump administration is bringing new instability to a sector already grappling with a shaky market as well as threats ...

Shares of GSK PLC GSK inched down 0.51% to £13.57 Friday, on what proved to be an all-around poor trading session for the ...

The pipeline will run for about 213 kilometres to a $7.4 billion polyethylene plant where construction started last September ...

Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for ...

At-home DNA testing is no longer in high demand — and critics have raised concerns about unreliable tests and privacy.

At J.P. Morgan, most biopharma executives expressed a neutral stance on the incoming administration, but just days later, ...

Plus: Moderna’s bird flu vaccine, Obamacare enrollment breaks records, and AstraZeneca’s new breast cancer treatment is FDA ...

Ozempic and Wegovy, Novo Nordisk’s GLP-1 drugs that treat diabetes and obesity, are on the list. Astellas Pharma’s prostate cancer drug, Xtandi, is also on the list — alongside AstraZeneca’s cancer ...

A small, but positive, randomized double-blind trial of baricitinib for PMR is the first in patients with the condition to ...